邹建军(兼职导师)

发布者:基础医学发布时间:2016-03-13浏览次数:170

邹建军(1974.9- ),男,湖南人。


【联系方式】

 办公电话:025-52887031, 手机号码:15380998951,邮箱:zoujianjun100@126.com

【研究方向】

                 药物代谢动力学、体内药物分析、药物基因组学、药动学-药效学结合模型、群体药动学。

【研究成果】

   主持和参与国家自然科学基金、省市级项目多项,获省市级科技进步奖和新技术引进奖多项,以第一作者或通讯作者等形式发表SCI论文30余篇。

[1]. Zou JJ, Di B, Wu CY, Hu Q, Li JH, Zhu Y, Fan H, Xiao D, Wang GJ. Pharmacokinetic and bioequivalence comparison of a single 100-mg dose of cefteram pivoxil powder suspension and tablet formulations: a randomized-sequence, open-label, two-period crossover study in healthy chinese adult male volunteers. Clin Ther. 2008, 30(4):654-660.

[2]. Zou JJ, Ji HJ, Wu DW, Yao J, Hu Q, Xiao DW, Wang GJ. Bioequivalence and pharmacokinetic comparison of a single 200-mg dose of meclofenoxate hydrochloride capsule and tablet formulations: a randomized sequence, open-label, two-period crossover study in healthy Chinese adult male volunteers. Clin Ther 2008, 30(9):1651-1657..

[3]. Zhu YB, Zou JJ*, Xiao DW, Fan HW, Yu CX, Zhang JJ, Yang J, Guo DQ. Bioequivalence of glucosamine sulfate capsules in fasting and healthy male chinese volunteers: an open-label, randomized, single-dose, two-way crossover study. Clin Ther 2009, 31:1551-1558..

[4]. Zou JJ, Dai L, Ding L, Xiao DW, Bin ZY, Fan HW, Liu L, Wang GJ. Determination of betamethasone and betamethasone 17-monopropionate in human plasma by liquid chromatography–positive/negative electrospray ionization tandem mass spectrometry. J Chromatogr B. 2008, 873(2):159-164.

[5]. Zou JJ, Bian XJ, Ding L, Zhu YB, Fan HW, Xiao DW. Determination of tegaserod by LC-ESI-MS/MS and its application to a pharmacokinetic study in healthy Chinese volunteers. J Chromatogr B. 2008, 861(1):151-157.

[6]. Xu L, Xiao DW, Lou S, Zou JJ*, Zhu YB, Fan HW, Wang GJ. A simple and sensitive HPLC-ESI-MS/MS method for the determination of andrographolide in human plasma. J Chromatogr B. 2009, 877(5):502-506.

[7]. Zhu YB, Zhang Q, Zou JJ, Yu CX, Xiao DW. Optimizing high-performance liquid chromatography method with fluorescence detection for quantification of tamoxifen and two metabolites in human plasma: Application to a clinical study. J Pharmaceut Biomed. 2008, 46:349-355.

[8]. Yu-Bing Zhu, Qian Zhang, Jian-Jun Zou, Cui-Xia Yu and Da-Wei Xiao. Optimizing high-performance liquid chromatography method with fluorescence detection for quantification of tamoxifen and two metabolites in human plasma: Application to a clinical study.Journal of Pharmaceutical and Biomedical Analysis. 2008, 46: 349-355.

[9]. Zou JJ, Xie HG, Chen SL, Tan J, Lin L, Zhao YY, Lin S, Zhang J, Wang GJ.    Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel treated Chinese patients under going percutaneous coronary intervention. Eur J Clin Pharmacol. 2013, 69:771-777.

[10]. Zou JJ, Chen SL, Tan J, Lin L, Zhao YY, Xu HM, Lin S, Zhang J, Fan HW, Xie HG. Increased Risk for Developing Major Adverse Cardiovascular Events in Stented Chinese Patients Treated with Dual Antiplatelet Therapy after Concomitant Use of the Proton Pump Inhibitor. PLOS ONE. 2014, 9(1): e84985.

[11]. Zou JJ,  Fan HW, Tan J, He BS, Chen SL, Xie HG, The CES1A -816C as a genetic marker for greater platelet clopidogrel: response in patients with percutaneous coronary intervention. J Cardiovasc Pharmacol2014, 63:178-183.  

[12]. Zou JJ, Fan HW, Chen SL, Tan J,He BS, Xie HG. Efffect of the ABCC3 -211C/T polymorphism on clopidogrel responsiveness in patients with percutaneous coronary intervention. Clin Exp pharmacol Physiol. 2013, 40:504-509.

[13]. Xie HG, Zou JJ, Hu ZY, Zhang JJ, Ye F, Chen SL. Individual variability in the disposition of and response to clopidogrel: pharmacogenomics and beyond. Pharmacol Therapeut 2011, 129:267-289..